Showing results 12572 to 12591 of 14621
< previous
next >
| Preview | Issue Date | Title | Author(s) |
| 2013 | Takotsubo cardiomyopathy after anti-influenza vaccination: catecholaminergic effects of immune system | Singh, K.; Marinelli, T.; Horowitz, J. |
| 2008 | Takotsubo cardiomyopathy following lightning strike | Dundon, B.; Puri, R.; Leong, D.; Worthley, M. |
| 2013 | Takotsubo cardiomyopathy mid ventricle variant and cardiac arrest: chicken or the egg? | Singh, K.; Parsaik, A.; Zeitz, C. |
| 2021 | Takotsubo syndrome: Finally emerging from the shadows? | Ong, G.J.; Nguyen, T.H.; Kucia, A.; Liu, S.-F.; Surikow, S.Y.; Girolamo, O.; Chong, C.-R.; Chirkov, Y.Y.; Schenck-Gustafsson, K.; Frenneaux, M.P.; Horowitz, J.D. |
| 2012 | Talc instillation consensus aids differentiating successful from unsuccessful pleurodesis: A survey on the interpretation of pleural approximation after chest tube placement | Boshuizen, R.; Vincent, A.; Kunst, P.; Ranasinha, S.; van den Heuvel, M. |
| 2013 | Tap63 regulates oncogenic miR-155 to mediate migration and tumour growth | Mattiske, S.; Ho, K.; Noll, J.; Neilsen, P.; Callen, D.; Suetani, R. |
| 2012 | Target concentration intervention in oncology: where are we at? | Saleem, M.; Dimeski, G.; Kirkpatrick, C.; Taylor, P.; Martin, J. |
| 2014 | Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia | Roberts, K.; Li, Y.; Payne-Turner, D.; Harvey, R.; Yang, Y.; Pei, D.; McCastlain, K.; Ding, L.; Lu, C.; Song, G.; Ma, J.; Becksfort, J.; Rusch, M.; Chen, S.; Easton, J.; Cheng, J.; Boggs, K.; Santiago-Morales, N.; Iacobucci, I.; Fulton, R.; et al. |
| 2017 | Targeted deletion of Traf2 allows immunosuppression-free islet allograft survival in mice | Villanueva, J.E.; Walters, S.N.; Saito, M.; Malle, E.K.; Zammit, N.W.; Watson, K.A.; Brink, R.; La Gruta, N.L.; Alexander, S.I.; Grey, S.T. |
| 2020 | Targeted disruption of bone marrow stromal cell-derived Gremlin1 limits multiple myeloma disease progression in vivo | Clark, K.C.; Hewett, D.R.; Panagopoulos, V.; Plakhova, N.; Opperman, K.S.; Bradey, A.L.; Mrozik, K.M.; Vandyke, K.; Mukherjee, S.; Davies, G.C.G.; Worthley, D.L.; Zannettino, A.C.W. |
| 2009 | Targeted disruption of the CXCL12/CXCR4 axis inhibits osteolysis in a murine model of myeloma-associated bone loss | Diamond, P.; Labrinidis, A.; Martin, S.; Farrugia, A.; Gronthos, S.; To, L.; Fujii, N.; O'Loughlin, P.; Evdokiou, A.; Zannettino, A. |
| 2012 | Targeted gene delivery of BMPR2 attenuates pulmonary hypertension | Reynolds, A.; Holmes, M.; Danilov, S.; Reynolds, P. |
| 2021 | Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer | Singhal, D.; Hahn, C.N.; Feurstein, S.; Wee, L.Y.A.; Moma, L.; Kutyna, M.M.; Chhetri, R.; Eshraghi, L.; Schreiber, A.W.; Feng, J.; Wang, P.P.-S.; Babic, M.; Parker, W.T.; Gao, S.; Moore, S.; Das, S.; Thomas, D.; Pattnaik, S.; Brown, A.L.; D'Andrea, R.J.; et al. |
| 2017 | Targeted LOWering of central blood pressure in patients with hypertension: baseline recruitment, rationale and design of a randomized controlled trial (The LOW CBP study) | Sharman, J.E.; Stanton, T.; Reid, C.M.; Keech, A.; Roberts-Thomson, P.; Stewart, S.; Greenough, R.; Stowasser, M.; Abhayaratna, W.P. |
| 2014 | Targeted peptide quantification of candidate plasma proteins to diagnose Transient Ischaemic Attack (TIA) | Djukic, M.; Milton, A.G.; Hamilton-Bruce, A.M.; Lewis, M.D.; Leung, E.; Jannes, J.; Chataway, T.; Koblar, S.A.; 25th Annual Scientific Meeting of the Stroke Society of Australasia (30 Jul 2014 - 1 Aug 2014 : Hamilton Island, Qld.) |
| 2012 | Targeted primary care-based mental health services for young Australians | Jureidini, J.N. |
| 2019 | Targeted resequencing identifies genes with recurrent variation in cerebral palsy | van Eyk, C.L.; Corbett, M.A.; Frank, M.S.B.; Webber, D.L.; Newman, M.; Berry, J.G.; Harper, K.; Haines, B.P.; McMichael, G.; Woenig, J.; MacLennan, A.H.; Gecz, J. |
| 2009 | Targeted treatment of imatinib-resistant chronic myeloid leukemia: Focus on dasatinib | Chuah, C.; Vaz de Melo, J. |
| 2013 | Targeting acute myeloid leukemia by dual inhibition of PI3K signaling and Cdk9-mediated Mcl-1 transcription | Thomas, D.; Powell, J.; Vergez, F.; Segal, D.; Nguyen, N.; Baker, A.; Teh, T.; Barry, E.; Sarry, J.; Lee, E.; Nero, T.; Jabbour, A.; Giovanna, P.; Green, B.; Manenti, S.; Glaser, S.; Parker, M.; Lopez, A.; Ekert, P.; Lock, R.; et al. |
| 2023 | Targeting Acute Myeloid Leukemia Using Sphingosine Kinase 1 Inhibitor-Loaded Liposomes. | Nguyen, T.M.; Jambhrunkar, M.; Wong, S.S.; Ross, D.M.; Joyce, P.; Finnie, J.W.; Manavis, J.; Bremmell, K.; Pitman, M.R.; Prestidge, C.A. |
